CGEN: Dhuwit awis diétung saben siji saham cgen.com

The cash per share metric for Compugen Ltd. (CGEN) reflects market expectations, with the parameter value equal to 1.24. This trend is driven by strategic alliances with pharma behemoths to accelerate antibody testing and the joint search for new oncological targets. Meanwhile, Compugen Ltd. (CGEN) leverages AI platforms and partner advances to scale revenue despite high research expenditures.
Rincian metrik komprehensif lan analitis Compugen Limited (CGEN)

Cash per share determines the absolute liquidity of the issuer, allowing an investor to assess the real value of the business considering available cash. By analyzing the cash position per share, one can judge the financial cushion of Compugen Ltd. (CGEN) for scaling its AI platform and reducing drug development costs without resorting to expensive external financing.